Europe Precision Medicine Market byTechnology (Big Data Analytics, Bioinformatics, Gene sequencing, Drug Discovery, Companion Diagnostic, and Others); End-users (Diagnostic tool companies, Healthcare IT/ Big data companies, Pharma & Biotech companies, and Clinical Labs); and for Application (Oncology, CNS,Immunology, Respiratory and Others) – Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 – 2024

Europe precision medicines market expected to reach USD 35,500.0 million by 2024, growing at a CAGR of more than 13% between 2017 and 2024.

Request Brochure Request Discount

22-Mar-2018 | Number of pages: 120 | Report Code: ZMR-2578 | Report Format : | Status : Published

Abstract

Report Brief

  • The report covers forecast and analysis for the precision medicines market on regional and country level.
  • The report includes the positive and the negative factors that are influencing the growth of the market.
  • Future opportunities about the Europe precision medicines market are discussed in the report.
  • The revenue generated by the prominent industry players has been analyzed in the report.
  • The market numbers have been calculated using top-down and the bottom-up approaches.
  • The precision medicines market has been analyzed using Porter’s Five Forces Analysis.
  • The market is segmented on the basis of technology, End-user, and applications, which in turn bifurcated on the country level as well.
  • All the segments have been evaluated based on the present and the future trends.
  • The report deals with the in-depth quantitative and qualitative analyses of the roof safety and access system market.
  • The report includes the detailed company profiles of the prominent market players.

Market Summary

The main aspect which will prompt the growth of the Europe precision medicine market is the increasing improved patient outcomes by using precision medicine. Moreover, the healthcare institutions in Europe are willing to use genetic testing and analytics technologies, payers willing to reimburse the cost of high-value drugs. Also, the drug companies that focus on developing new personalized therapies, companion diagnostics providers that propels the improvements in information gathering, and genetic analytics services which help interpret the results. Considering all the above factors the market for precision medicines in Europe is expected to propel significantly during the forecast period.

Value

The Europe precision medicine market was valued at around USD 33,200.0 million in the year 2014 and it is expected to reach approximately USD 35,000.0 million by 2024. The Europe precision medicine market is expected to grow at aCAGR of over13% between 2017 and 2024.

Drivers and Restraints

The major factor driving the growth of Europe precision medicine market is the Increasing demand for personalized treatment. A large number of established online forums in the region, which help clinicians collaborate with one another and share information, which will help in the diagnosis and treatment of patients in a better manner.Increasing focus on targeted therapy by reducing trial and error medicine, advancement of technology in understanding human biology & disease susceptibility, and a shift in the significance of medicine from reaction to prevention, among others will propel the precision medicines market in near future.

However, several clinical, economic, ethical and regulatory conditions will continue to challenge the growth of this industry in the years to come.

Global Europe Precision Medicine Market

Segmentation

Big data analytics technology segment is accounted for the largest market share in 2017 and expected to dominate the market by the end of forecast period. Healthcare information technology platforms becoming more widely available that securely store and analyze vast amounts of electronic health record data from thousands of patients, providing doctors with new information and insight to help them deliver more personalized care to their patients.

The diagnostic tool companies segment dominates the European precision medicines market by end-users. Use of comprehensive profiling for patients to determine an appropriate treatment is one of the major advantages of precision medicines This includes not just genetics, but family history, diet, exercise, stress level and more. These factors enable a healthcare provider to develop an effective treatment plan that is not based on the average patient, but the individual patient, instead. Considering all the factors the diagnostic tool companies plays a major role in precision medicine market and hence contribute for the largest share.

Considering the applications of precision medicine market, Oncology segment is anticipated to hold the largest market share. In oncology, the genetic information provides the understanding that not only do tumors differ within tumor heterogeneity, but the information clearly shows that each patient’s individual tumor is an assemblage of inimitable molecular irregularities that will require an equally exclusive personalized therapeutic regimen. This has increased the preference for precision medicine in oncology applications.

Germany contributes to the largest market share of Europe precision medicine market. U.K. is expected to grow at high CAGR for the precision medicine deployments in Europe, due to different kinds of solutions being offered and services being delivered in the country. Moreover, countries such as Spain, France, and Italy have shown tremendous growth in precision medicine solution developments. 

Industry Players

The report includes detailed profiles of the prominent market players that are trending in the market. The list of the players that are compiled in the report areRoche, QIAGEN N.V., Cepheid, Inc, Johnson & Johnson Services, Inc., Illumina, Almac Group, bioMérieux SA, Intel Corporation, GE Healthcare, Novartis, Thermo Fisher Scientific, and much more.

The prominent market players maintain the competitive edge in the global market by making investments in the mergers and acquisitions and by increasing their product portfolio. For instance recently on 8th January 2018, GE Healthcare and pharmaceutical giant Roche announced a partnership to develop and co-market digital clinical decision support solutions.  The companies said that they will focus on precision medicine products to accelerate and improve individualized treatments for cancer and critical care patients.


Related Reports

Plant Sterol Esters Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3522 | Report Format:

Global Plant Sterol Esters Market: Overview Sterol esters are the heterogeneous chemical composites that are found in tiny proportions in eachcell type. These compounds are produced when sterol and fatty acids are esterified. Furthermore, plant sterols, which are found in fatty tissues of plants...Read More

Pharmaceutical Intermediates Market by Product Type (GMP and Non GMP), by Applications (Antibiotics, Antipyretic analgesics, Vitamins, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3440 | Report Format:

The report covers forecast and analysis for the pharmaceutical intermediates market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pharmac...Read More

Cellulite Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3436 | Report Format:

Global Cellulite Treatment Market: Overview The condition where a persons skin has a lumpy and dimpled appearance is known as cellulite. In this condition, the skin on ones thighs, stomach, and buttocks get affected generally. The growing consciousness regarding ones appearance and rise in the p...Read More

Albumin Market by Product (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), by Application (Therapeutics & Diagnostics, Drug Delivery, Vaccine Ingredient, Culture Medium Ingredient & Stabilizer, In-vitro Fertilization, and Others), and by End-User (Pharmaceutical & Biotechnology Industry, Research Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3434 | Report Format:

The report covers forecast and analysis for the albumin market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the albumin market along with th...Read More

Drug Designing Tools Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3432 | Report Format:

Global Drug Designing Tools Market: Overview Drug designing tools refer to computer modeling proficiencies that offer insights into findings of experimental nature. These tools utilize computational chemistry for discovering, enhancing, and studying varied drugs and their related active biologic...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.